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Cardiac hemangioma is one of the rare benign primary cardiac tumors 
with an incidence of 1% to 2%. To date, less than 15 cases of cardiac 
hemangioma causing RVOT obstruction have been reported.
(2) Posterior Mediastinal Vascular Malformation: A rare case of a 27-
year-old male with an incidental ﬁnding of a right lung mass on chest 
radiograph and was conﬁrmed as a posterior mediastinal mass on CT 
scan. The patient underwent thoracotomy to debulk the tumor, how-
ever, the procedure was aborted due to tremendous bleeding. The tissue 
samples submitted revealed an arteriovenous malformation and was 
conﬁrmed on special and immunohistochemical staining. The patient 
was then scheduled for angiogram and embolization.
Most tumors of the posterior mediastinum are neurogenic in origin. An 
arteriovenous malformation in the posterior mediastinum is a very rare 
neoplasm with only 2 reported cases. To the best of our knowledge, this 
seems to be the third reported case of posterior mediastinal arteriove-
nous malformation (AVM).
(3) Pulmonary Sclerosing Hemangioma: A rare case diagnosed by 
frozen section biopsy in a 41 year old asymptomatic female who pre-
sented with a solitary pulmonary nodule discovered on routine annual 
medical chest radiograph. Immunohistochemical stains such as Thyroid 
Transcription Factor I (TTFI), Epithelial Membrane Antigen (EMA) 
and Cytokeratin were done. 
Pulmonary Sclerosing Hemangiomas are rare, slowly growing benign 
neoplasms of uncertain histogenesis. 
Results: Vascular lesions are difﬁcult to diagnose for the inexperienced 
pathologist, clinician and thoracic surgeon. These lesions must be 
properly evaluated prior to any surgical procedure to prevent further 
complications such as bleeding. For pathologists, differentiating hem-
angiomas from other vascular tumors are difﬁcult because most often 
and commonly in these three presented cases, biopsy material sent to 
the laboratory is inadequate and not representative of the entire mass. 
With minimal surgical specimen, the pathologist was able to conﬁrm 
the benign nature of the lesion with immunohistochemical stains such 
as CD 31, S100, Factor VIII and elastic stain.
Conclusion: We have presented three thoracic vascular tumors to 
increase the awareness that although these tumors are rare and histo-
logically benign, they may be life-threatening. Its treatment requires 
careful judgment and multidisciplinary team approach with the thoracic 
surgeon, cardiologist, pulmonologist and pathologists as well. 
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Background: CD4+CD25+ Regulatory T cells (Tregs) have been 
shown to suppress host immune responses to a variety of cancers. 
Nuclear Foxp3 is currently the only speciﬁc marker for regulatory T 
cells. We describe the presence and pattern of Foxp3+ lymphocyte inﬁl-
tration in human non-small cell lung cancers, conﬁrming the presence 
of regulatory T cells with the hope of future immune targeted therapies.
Methods: Sixteen cases of formalin ﬁxed parafﬁn embedded lung 
tissue were selected from the pathology archives, [13 primary lung car-
cinomas (5 squamous cell carcinoma, 4 adenocarcinoma, 3 adenocar-
cinoma with bronchoalveolar features (BACF), and 1 bronchoalveolar 
carcinoma (BAC), 2 inﬂammatory (1 bronchiectasis and 1 interstitial 
ﬁbrosis) and 1 metastatic thyroid carcinoma]. Ages were 39-83 years, 
there were 10 women. The tissue was incubated with 1:50 dilution 
of puriﬁed anti-Foxp3 antigen (Biolegend). The amount of lymphoid 
stroma was measured as the percent of lymphoid tissue within 10 tumor 
high power ﬁelds (hpf- 20x).The percent of Foxp3 positive lympho-
cytes within each lymphoid aggregate was measured as percent positive 
per aggregate (40x). These were multiplied to give a Treg expression 
index (Foxp3 expression/aggregate)(number of aggregates).
Results: Squamous carcinoma had the least amount of lymphoid tissue 
(4.2%) and BAC/BACF had the greatest (6%). The greatest number of 
Tregs per hpf lymphoid tissue was in the metastasis (40/ﬁeld) and least 
in inﬂammation (17.5/ﬁeld). The highest Treg index was in the case of 
pulmonary metastasis (200). Of the primary lung tumors, adenocarcino-
ma (181), BAC (162) and BACF (146) were the highest. Inﬂammation 
(96.2) and squamous carcinoma (83.2) were at the low end. No trend 
was identiﬁed regarding location of lymph tissue at the tumor interface 
or within the tumor. 
Conclusions: All lymphoid aggregates showed a sprinkling of Foxp3 
positive nuclei suggesting that Tregs are present in all inducible lym-
phoid tissue, with variations in tumor type and total lymphoid quantity. 
Tumors that induced a greater amount of lymphoid stroma tended to 
have the greatest Foxp3 index. We did not ﬁnd any case without at least 
scant Treg presence. Future immune directed therapeutic intervention 
may be possible after understanding the presence and pattern of these 
cells in non-small cell lung cancers.
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Background: Survivin is a member of the inhibitors of apoptosis (IAP) 
gene family that acts through pathways different from those involving 
the bcl-2 family. Largely undetectable in normal adult tissues, survivin 
is deregulated in most human cancers including non-small-cell lung 
cancer (NSCLC) and may represent a tumor marker with prognostic 
and therapeutic implications. Aim of our study was to determine the 
prognostic role of survivin as an apoptosis-related biomarker in a series 
of early-stage NSCLC patients.
Methods: A retrospective series of resected NSCLC patients was 
retrieved from the ﬁles of the Regina Elena National Cancer Insti-
tute. Survivin was detected by immonohistochemistry (IHC) using a 
polyclonal antibody. Survivin displayed two kinds of immunoreactiv-
ity: a diffuse cytoplasmic staining and a distinct nuclear staining. A 
score-scale to distinguish positive (score 1-2) versus negative (score 0) 
pattern was applied. Clinical and biological (nuclear and cytoplasmic 
survinin staining) covariables were screened for a prognostic rela-
tionship with overall (OS) and progression free-survival (PFS) into a 
univariate and multivariate analysis. 
Results: Data referring to 116 NSCLC patients who underwent surgery 
for stage I-IIIA NSCLC were collected. Multivariate analyses identiﬁed 
tumor size, nodal status and nuclear, but not cytoplasmic, expression 
of survivin as signiﬁcant independent predictors of OS, with an hazard 
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ratio of 2.40 (95% CI 1.44, 3.99, p=0.001), 2.03 (95% CI 1.26, 3.26, 
p=0.003) and 1.83 (95% CI 1.01, 3.30, p=0.044), respectively. Median 
OS for nuclear-survivin positive (score 1-2) and negative (score 0) pa-
tients were 23 months (95% CI 15, 31) and 36 months (95% CI 1, 76), 
respectively (p=0.01); 5-yr survival for score 1-2 and score 0 patients 
were 20% and 44.5%, respectively. Conversely, no signiﬁcant impact 
on survival is found for patients stratiﬁed according to cytoplasmic 
survivin expression.
Conclusions: Data presented herein open the issue that prognosis of 
early stage of NSCLC can be linked to the cellular pattern of distribu-
tion of survivin. 
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Cale-Subia, Laarnie N.; Sagun, Leonisa S.; De Luna, Arlene M. 
Philippine Heart Center, Quezon City, Philippines
Background: Cardiac neoplasms are a rare occurrence in clinical prac-
tice. Here, we present a case of a benign cardiac tumor with a history of 
previous uterine leiomyoma.
Objective: To describe a case of a rare benign cardiac tumor consid-
ered as benign metastasizing leiomyoma against primary cardiac tumor 
and underscore the usefulness of immunohistochemistry at arriving at 
the deﬁnitive diagnosis. 
Case Methodology: A 45-year old female was managed as a case 
of renal disease and found out to have a right atrial mass with signs 
of tamponade. Imaging diagnostics revealed a mass within the right 
atrium and inferior vena cava with a consideration of myxoma. Exci-
sion showed right atrial mass with inferior vena cava extension, the 
stalk is attached to the posterior of IVC. A benign spindle cell tumor 
favoring atypical leiomyoma was considered after a positive smooth 
muscle actin and negative S-100. Further immunohistochemistry of the 
patient’s uterine leiomyoma, showed positive estrogen receptor (ER), 
progesterone receptor (PR) and negative p53 while the cardiac mass 
showed negative reaction to ER, PR, and p53. The patient was weaned 
from cardiopulmonary bypass without difﬁculty. 
Results And Discussion: The patient is in her reproductive years, the 
usual presentation of primary cardiac neoplasms and benign metasta-
sizing leiomyoma. Benign metastasizing leiomyoma are usually found 
in the lungs with unclear pathogenesis after hysterectomy for uterine 
leiomyoma. Benign primary cardiac tumours are rare entities. The 
majority are myxomas (70%) with the rest as non-myxomatous. The 
patient presented with congestion because of large intracavitary mass 
occluding the right atrium that then causes hemodynamic insufﬁciency. 
Excision resolved the signs and symptoms. Tissue examination showed 
benign spindle cell tumor with hypercellular areas showing focal 
moderate atypia and lacking areas of tumor cell necrosis, hemorrhage 
with nil mitotic activity. A positive SMA and negative S-100 favors 
the diagnosis of atypical leiomyoma since primary cardiac leiomyoma 
is not reported in literature. Benign metastasizing leiomyoma is also 
entertained with history of uterine leiomyoma. This presents 10% 
cardiac involvement and may be misdiagnosed as a primary cardiac 
tumor. With negative ER, PR and p53, the cardiac tumor is conﬁrmed 
as primary cardiac leiomyoma. 
Conclusion: Benign cardiac neoplasms are extremely rare, with few 
being reported in literature. This is a case of 45-year old female with 
congestive heart failure and tamponade who incidentally found out to 
have a solid intracavitary mass on the right atrium. Tissue examination 
showed atypical leiomyoma after positive SMA. With history of uterine 
leiomyoma, benign metastasizing leiomyoma was entertained. Further 
immunostaining showed uterine leiomyoma with positive ER-PR and 
negative p53 against the cardiac tumor with negative ER-PR and p53 
thus conﬁrming the diagnosis of primary cardiac leiomyoma. 
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Background: It has been very difﬁcult to preoperatively distinguish 
large cell neuroendocrine carcinoma of the lung (LCNEC) not only 
from small cell lung cancer (SCLC) but also from non-small cell lung 
cancer (NSCLC) except LCNEC because only a small tissue specimen 
for histological examination can be obtained preoperatively. Enough 
quantity of cytological specimens can be obtained by bronchoscop or 
percutaneous ﬁne needle aspiration, so that cytological evaluation may 
be much useful and helpful to the preoperative diagnosis.
Methods: Tumor touch imprint cytological specimens of surgically 
resected NSCLC from Jan 2002 to Jan 2007 were studied. All the 
cases were histologically diagnosed as NSCLC. Immunocytochemistry 
was done by using the following primary antibodies; chrmogranin A, 
synaptophysin, neural cell adhesion molecule, neuron speciﬁc enolase, 
cytokeratin34βE12, cytokeratin18, E-cadherin and thyroid transcription 
factor-1.
Results: Histological diagnoses of twenty-six cases examined were as 
follows; LCNEC in two cases, adenocarcinoma in ﬁfteen cases, squa-
mous cell carcinoma in eight, and adenosquamous carcinoma in one. 
All LCNEC showed positive staining of chromograin A and negative 
staining of cytokeratin34βE12. All NSCLC except LCNEC showed 
negative staining of chromogranin A, and 88% of them showed positive 
staining of cytokeratin34βE12.
Conclusion: The current study revealed immunocytochemistry help us 
distinguish LCNEC accurately from other NSCLC, and indicated posi-
tive staining of chromogranin A and negative of 34βE12 is important 
to diagnose LCNEC cytologically. Final results of a total of a hundred 
cases will be presented. 
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Vascular malformation in the posterior mediastinum: Report of a 
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Background: Arteriovenous malformations (AVM) are the most 
important type of vascular malformation and these can cause signiﬁcant 
morbidity and even mortality especially if deep soft tissue structures 
are involved. Their unorthodox locations and different clinical presen-
tations create concern to the part of clinicians, radiologists, patholo-
gists, and surgeons. As of today, only two cases of AVM in the posterior 
mediastinum have been reported and published.
Objective: To report a rare case of arteriovenous malformation (AVM) 
in the posterior mediastinum and present data and review of literature 
on rare posterior mediastinal tumors.
